Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Greece Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20173
20191
20202
20211
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
European Organisation for Research and Treatment of Cancer - EORTC2
Astellas Pharma Global Development, Inc.1
Boehringer Ingelheim1
Janssen Research & Development, LLC1
Kura Oncology, Inc.1
Sellas Life Sciences Group1
Syndax Pharmaceuticals1
Takeda1
Vion Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute14
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Non-Hodgkin3
Multiple Myeloma3
Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Blast Crisis2
Burkitt Lymphoma2
Dendritic Cell Sarcoma, Interdigitating2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.